Castle Biosciences (CSTL) Asset Utilization Ratio (2019 - 2026)

Castle Biosciences (CSTL) has 8 years of Asset Utilization Ratio data on file, last reported at 0.6 in Q1 2026.

• Quarterly Asset Utilization Ratio fell 10.19% year-over-year to 0.6 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.6 (down 10.19% YoY) and the FY2025 annual result came in at 0.62, down 8.03% from the prior year.
• Asset Utilization Ratio was little changed at 0.6 in Q1 2026 per CSTL's latest filing, from 0.6 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.67 in Q1 2025, with the low at 0.22 in Q1 2022.
• Average Asset Utilization Ratio over 5 years is 0.49, with a median of 0.55 recorded in 2024.
• Year-over-year, Asset Utilization Ratio jumped 65.04% in 2023 and decreased 10.19% in 2026.
• Castle Biosciences' Asset Utilization Ratio stood at 0.3 in 2022, then surged by 63.23% to 0.49 in 2023, then advanced by 28.49% to 0.64 in 2024, then decreased by 5.02% to 0.6 in 2025, then advanced by 0.06% to 0.6 in 2026.
• Business Quant data shows CSTL's Asset Utilization Ratio at 0.6 in Q1 2026, 0.6 in Q4 2025, and 0.62 in Q3 2025.